DPIIT recognised startup Government of India
Startup India
Series 5 Labs Private Limited - information technology in Bangalore, Karnataka, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹82,560
▼ 70% YoY
Net loss · FY 2025
₹7.34 Lakh
Latest filing
EBITDA · FY 2025
-₹7.32 Lakh
Latest filing
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹1.04 Lakh
Issued & subscribed
Company age
10 yrs
Est. 2016
Directors on board
2
As per MCA filings
GST registrations
1
None active
About Series 5 Labs Private Limited
Data last updated:
Series 5 Labs Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the application development and software solutions segment of the technology and IT services sector. It was incorporated on 22 December 2016 and has been in existence for over 10 years.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U72900KA2016PTC098692. The company has 1 GST registration on record, which is no longer active.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1.04 Lakh. It is led by directors Karakkad Parambil Vishwanathan Vijisha and Bhooshan Chandra Saro.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at # No. 314 Synapse Nest 7/3 Itpl Main Road Thuberahalli, Bangalore, Karnataka, India – 560037.
As per the financials filed for FY 2025, the company reported a revenue of ₹82,560, a decline of 70% compared to the previous year. For the same year it recorded a net loss of ₹7.34 Lakh and EBITDA of -₹7.32 Lakh. Revenue has declined at a compounded annual rate (CAGR) of 14% over three years and 15% over five years.
The company is associated with 1 brand: Series-5 Lab. Court records list 4 cases involving the company, including 3 filed by the company and 1 filed against it; 4 cases are pending. The company has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in March 2019. Its 8 peer companies in the same principal business activity (other professional, scientific and technical activities) are compared by revenue, 3 larger and 5 smaller; the largest is Pramathadhip Resource Private Limited with revenue of ₹82,800.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website series-5.com.
Company details
CIN U72900KA2016PTC098692
Registration Number 098692
Incorporation Date 22 December 2016
ROC Bangalore
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
DPIIT Recognition Recognised Startup
Recognitions & Rankings of Series 5 Labs
Contact details
Series 5 Labs Private Limited's registered office is in Bangalore, Karnataka. Its website is series-5.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered Address# No. 314 Synapse Nest 7/3 Itpl Main Road Thuberahalli, Bangalore, Karnataka, India – 560037
- IndustryInformation Technology, Application Development & Software Solutions
To see the full contact details of Series 5 Labs Private Limited, buy the company report.
Comprehensive company report
Series 5 Labs Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Brands
Series 5 Labs operates one associated brand: Series-5 Lab. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| A software-defined marketing platform is provided for diverse sectors. | series-5.com |
Business activity
The main business activity of Series 5 Labs is professional, scientific and technical. In detail, this covers other professional, scientific and technical activities.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| M | Professional, Scientific and Technical | M9 | Other professional, scientific and technical activities |
To see the full business activity and turnover split of Series 5 Labs Private Limited, buy the company report.
Financials of Series 5 Labs Private Limited
FY 2025 filings availableSeries 5 Labs Private Limited reported revenue of ₹82,560 (down 70% YoY) for FY 2025.
Revenue · FY 2025
₹82,560 ▼ 70%
Net loss · FY 2025
₹7.34 Lakh
EBITDA · FY 2025
-₹7.32 Lakh
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 70%
3 years · compounded
▼ 14%
5 years · compounded
▼ 15%
EBITDA CAGR growth
1 year
▲ 49%
3 years · compounded
▼ 88%
5 years · compounded
▲ 3%
Revenue has declined at a compounded annual rate (CAGR) of 15% over five years, including a 70% fall in the latest year. EBITDA rose 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | -₹7.32 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | -₹7.34 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | |||||
| Net Profit Margin | |||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Series 5 Labs Private Limited, buy the company report.
Board of directors of Series 5 Labs Private Limited
Series 5 Labs has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Karakkad Parambil Vishwanathan Vijisha Also directs: Connect2sun Technologies Private Limited | Director | 22 Dec 2016 | 9 Years 10 Months | Current |
| Bhooshan Chandra Saro Also directs: Connect2sun Technologies Private Limited | Director | 15 Jun 2018 | 8 Years 4 Months | Current |
Peer comparison
Series 5 Labs Private Limited is compared with the 8 companies closest to it by revenue in the same principal business activity (other professional, scientific and technical activities), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Pramathadhip Resource Private Limited | ₹82,800 (FY 2024) | 8.0% | Delhi, India | |||
| DJK Dzine Matters Interiors Private Limited | ₹82,797 (FY 2023) | -88.0% | Kolkata, West Bengal, India | |||
| Aiseon Healthcare Technologies Private Limited | ₹82,592 (FY 2024) | Nariman Point, Mumbai, Maharashtra, India | ||||
| Series 5 Labs Private Limited this company | ₹82,560 (FY 2025) | -₹7.34 Lakh | -70.0% | Bangalore, Karnataka, India | ||
| Ultimate Balancing Services India Private Limited | ₹82,500 (FY 2025) | 9.0% | Jaipur, Rajasthan, India | |||
| Compcare Software Private Limited | ₹82,358 (FY 2017) | 20.0% | Chennai, Tamil Nadu, India | |||
| ZSS Technologies Private Limited | ₹82,330 (FY 2024) | Bangalore, Karnataka, India | ||||
| Quick Corporate Services Private Limited | ₹82,326 (FY 2025) | -22.0% | Delhi, India | |||
| Vision Leadership Training Private Limited | ₹82,298 (FY 2020) | -91.0% | New Delhi, Delhi, India |
To see the full peer comparison of Series 5 Labs Private Limited, buy the company report.
Auditor
Series 5 Labs Private Limited is audited by SUJA AND SRINIVAS for the financial year 2018.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| SUJA AND SRINIVAS | FY 2018 | 017335S |
Shareholding
The shareholding of Series 5 Labs Private Limited is on record for 2 financial years, the latest being FY 2018, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2018 | FY 2017 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Series 5 Labs Private Limited, buy the company report.
Deals & funding
Series 5 Labs Private Limited has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in March 2019.
Total deals
4
Rights issues
2
Secondary share transfers
2
Deals on record (4 of 4)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Rights issue | ₹20 Lakh | Investors: 2 individuals |
| Jul 2018 | Rights issue | ₹15 Lakh | Investors: 2 individuals |
| May 2018 | Secondary share transfer | Undisclosed | Buyer: an individual Seller: 2 individuals |
| Mar 2018 | Secondary share transfer | Undisclosed | Buyer: IIM Bangalore Seller: 3 individuals |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Series 5 Labs Private Limited has 4 court cases on record: 3 filed by Series 5 Labs, 1 filed against it. All cases are pending.
Total cases
4
Filed by the company
3
Filed against the company
1
Pending
4
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
| High courts | 2 | 1 | 2 |
Cases on record (4 of 4)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, KARNATAKA | Court case (CCC) | Filed by the company against M/S Transhelp Technologies Private Limited and 4 others | Pending |
| District court, BENGALURU, Karnataka | Interim or miscellaneous application | Filed by the company against M/S Transhelp Technologies Private Limited | Pending |
| District court, BENGALURU, Karnataka | Civil suit | Filed by the company against M/S Transhelp Technologies Private Limited | Pending |
| High Court | Court case (MFA) | Filed against the company by M/S Transhelp Technolotgies Private Limited and 4 others | Pending |
To see the full case history of Series 5 Labs Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Series 5 Labs Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Series 5 Labs has 1 GST registration on record, and it has been cancelled or is inactive. Only active GST numbers are listed on this page.
Total GSTINs
1
Cancelled / inactive
1
To see the full GST registrations and return filing status of Series 5 Labs Private Limited, buy the company report.
Recent activity
Series 5 Labs Private Limited has 5 board changes on record since 2016: 2 appointments and 3 cessations. The latest: Bhooshan Chandra Saro ceased to be Additional Director on 30 Sep 2018.
AGM
Series 5 Labs Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Series 5 Labs Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Bangalore.
Ceased
Bhooshan Chandra Saro ceased to be Additional Director.
Appointed
Bhooshan Chandra Saro was appointed as Director.
Ceased
Parameswarannair Suresh Kumar ceased to be Director.
Ceased
Sumitha Thykeel ceased to be Director.
Appointed
Karakkad Parambil Vishwanathan Vijisha was appointed as Director.
Incorporation
22 Dec 2016
Series 5 Labs Private Limited was registered on 22 Dec 2016 with Roc Bangalore & aged 9 years 10 months as per MCA records.
Frequently asked questions
Series 5 Labs is an active private limited company based in Bangalore, Karnataka, India. The company works in application development and software solutions, within the information technology industry. It was incorporated on 22 December 2016 (10+ years old) and is registered under CIN U72900KA2016PTC098692.
Series 5 Labs has 2 current directors:
- Karakkad Parambil Vishwanathan Vijisha - Director
- Bhooshan Chandra Saro - Director
The latest financial statements of Series 5 Labs on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2017 are in the company report.
No. Series 5 Labs has 1 GST registration on record and it is cancelled or inactive.
The CIN (Corporate Identification Number) of Series 5 Labs is U72900KA2016PTC098692. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Series 5 Labs has 4 court cases on record: 3 filed by the company and 1 filed against it. 4 are pending. Most are in the district courts.
Series 5 Labs was incorporated on 22 December 2016, making it 10+ years old. It is registered with the Registrar of Companies, Bangalore.
Series 5 Labs has 4 deals on record (2 rights issues, 2 secondary share transfers); the latest was in March 2019.
The peers of Series 5 Labs by revenue are Pramathadhip Resource Private Limited, DJK Dzine Matters Interiors Private Limited, Aiseon Healthcare Technologies Private Limited, Ultimate Balancing Services India Private Limited, Compcare Software Private Limited and 3 more, all in the same principal business activity (other professional, scientific and technical activities).
Bhooshan Chandra Saro ceased to be Additional Director on 30 Sep 2018. Bhooshan Chandra Saro was appointed as Director on 15 Jun 2018. Parameswarannair Suresh Kumar ceased to be Director on 15 Jun 2018. Series 5 Labs has 5 board changes on record in total.
Yes, Series 5 Labs is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).